NO991548L - Anvendelse av mupirocin for fremstilling av et medikament for behandling av bakterieinfeksjoner forÕrsaket i forbindelse med kolonisering av nasofarynks med patogene organismer - Google Patents

Anvendelse av mupirocin for fremstilling av et medikament for behandling av bakterieinfeksjoner forÕrsaket i forbindelse med kolonisering av nasofarynks med patogene organismer

Info

Publication number
NO991548L
NO991548L NO991548A NO991548A NO991548L NO 991548 L NO991548 L NO 991548L NO 991548 A NO991548 A NO 991548A NO 991548 A NO991548 A NO 991548A NO 991548 L NO991548 L NO 991548L
Authority
NO
Norway
Prior art keywords
mupirocin
nasopharynx
colonization
drug
manufacture
Prior art date
Application number
NO991548A
Other languages
English (en)
Norwegian (no)
Other versions
NO991548D0 (no
Inventor
Anthony Guy Hatton
Timothy John Henkel
Jane Elizabeth Hilton
Hugh Purdie Scott
Teresita Regina Geradin Tallon
Original Assignee
Smithkline Beecham Corp
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9716805.8A external-priority patent/GB9716805D0/en
Priority claimed from GBGB9719203.3A external-priority patent/GB9719203D0/en
Application filed by Smithkline Beecham Corp, Smithkline Beecham Plc filed Critical Smithkline Beecham Corp
Publication of NO991548D0 publication Critical patent/NO991548D0/no
Publication of NO991548L publication Critical patent/NO991548L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO991548A 1996-10-01 1999-03-30 Anvendelse av mupirocin for fremstilling av et medikament for behandling av bakterieinfeksjoner forÕrsaket i forbindelse med kolonisering av nasofarynks med patogene organismer NO991548L (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US2722396P 1996-10-01 1996-10-01
US2722496P 1996-10-01 1996-10-01
US2722296P 1996-10-01 1996-10-01
GBGB9716805.8A GB9716805D0 (en) 1997-08-09 1997-08-09 Novel composition and use
GBGB9719203.3A GB9719203D0 (en) 1997-09-11 1997-09-11 Novel composition and use
PCT/GB1997/002664 WO1998014189A1 (en) 1996-10-01 1997-09-29 Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms

Publications (2)

Publication Number Publication Date
NO991548D0 NO991548D0 (no) 1999-03-30
NO991548L true NO991548L (no) 1999-03-31

Family

ID=27517419

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991548A NO991548L (no) 1996-10-01 1999-03-30 Anvendelse av mupirocin for fremstilling av et medikament for behandling av bakterieinfeksjoner forÕrsaket i forbindelse med kolonisering av nasofarynks med patogene organismer

Country Status (17)

Country Link
US (1) US6001870A (ja)
EP (1) EP0939631A1 (ja)
JP (1) JP2001504091A (ja)
KR (1) KR20000048812A (ja)
CN (1) CN1239427A (ja)
AR (1) AR010995A1 (ja)
AU (1) AU724070B2 (ja)
BR (1) BR9711843A (ja)
CA (1) CA2267248A1 (ja)
CZ (1) CZ112499A3 (ja)
HU (1) HUP9904308A3 (ja)
IL (1) IL129237A0 (ja)
NO (1) NO991548L (ja)
NZ (1) NZ334913A (ja)
PL (1) PL332642A1 (ja)
TR (1) TR199900733T2 (ja)
WO (1) WO1998014189A1 (ja)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4910145A1 (es) 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
CA2267248A1 (en) * 1996-10-01 1998-04-09 Smithkline Beecham P.L.C. Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
CA2299298A1 (en) * 1997-08-09 1999-02-18 Jane Elizabeth Hilton Compositions for nasal administration
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
GB9808470D0 (en) 1998-04-22 1998-06-17 Smithkline Beecham Plc Novel process and apparatus
GB9902138D0 (en) 1999-02-02 1999-03-24 Smithkline Beecham Container
US6509177B1 (en) * 1999-02-03 2003-01-21 Biogal Gyogyszergyar Rt. Process for the preparation of pseudomonic acid A antibiotic by microbiological method
JP2004525854A (ja) * 1999-06-02 2004-08-26 ヘキサル・アクチェンゲゼルシャフト 水中に不溶性及び／又は難溶性である活性物質の鼻腔内投与用薬剤組成物
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6676930B2 (en) * 1999-11-28 2004-01-13 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
HUP0500797A2 (en) * 2001-06-21 2007-06-28 Biogal Gyogyszergyar Metabolic controlled fermentation process for pseudomonic acid production
US7737177B2 (en) * 2001-12-28 2010-06-15 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság Processes for preparing crystalline and amorphous mupirocin calcium
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
MXPA06010084A (es) * 2004-06-01 2007-03-01 Teva Gyogyszergyar Zartkoruen Proceso para la preparacion de forma amorfa de un farmaco.
CA2599653A1 (en) 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of reducing microbial contamination
CA2599667C (en) 2005-03-10 2014-12-16 3M Innovative Properties Company Antimicrobial compositions comprising esters of hydroxy carboxylic acids
EP1858506A2 (en) * 2005-03-10 2007-11-28 3M Innovative Properties Company Methods of treating ear infections
GB2437488A (en) * 2006-04-25 2007-10-31 Optinose As Pharmaceutical oily formulation for nasal or buccal administration
US7959943B2 (en) 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US7976873B2 (en) 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US8088095B2 (en) 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
WO2009152374A2 (en) 2008-06-12 2009-12-17 Medtronic Xomed, Inc. Method for treating chronic wounds
US20100021563A1 (en) * 2008-07-24 2010-01-28 Paul Levesque Compositions comprising coconut oil and methods of use thereof
US20100086576A1 (en) 2008-10-06 2010-04-08 Myntti Matthew F Antimicrobial composition and methods of making and using same
EP2706845B1 (en) 2011-05-10 2021-06-23 Next Science IP Holdings Pty Ltd Antimicrobial solid and methods of making and using same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ200918A (en) * 1981-07-02 1985-07-31 Gist Brocades Nv Stable fatty oil-in-water emulsion cream for topical application
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
GB8415579D0 (en) * 1984-06-19 1984-07-25 Beecham Group Plc Compounds
GB8530796D0 (en) * 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
IE59628B1 (en) * 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
US5594026A (en) * 1990-12-11 1997-01-14 Smithkline Beecham Group P.L.C. Polymorphs of crystalline mupirocin
ES2157996T3 (es) * 1993-10-22 2001-09-01 Smithkline Beecham Corp Nueva composicion.
CA2267248A1 (en) * 1996-10-01 1998-04-09 Smithkline Beecham P.L.C. Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms

Also Published As

Publication number Publication date
AR010995A1 (es) 2000-08-02
US6001870A (en) 1999-12-14
AU4562397A (en) 1998-04-24
CN1239427A (zh) 1999-12-22
WO1998014189A1 (en) 1998-04-09
TR199900733T2 (xx) 1999-07-21
AU724070B2 (en) 2000-09-14
CA2267248A1 (en) 1998-04-09
IL129237A0 (en) 2000-02-17
EP0939631A1 (en) 1999-09-08
PL332642A1 (en) 1999-09-27
CZ112499A3 (cs) 1999-08-11
NO991548D0 (no) 1999-03-30
KR20000048812A (ko) 2000-07-25
JP2001504091A (ja) 2001-03-27
BR9711843A (pt) 2001-07-31
NZ334913A (en) 2001-03-30
HUP9904308A3 (en) 2002-06-28
HUP9904308A2 (hu) 2001-04-28

Similar Documents

Publication Publication Date Title
NO991548L (no) Anvendelse av mupirocin for fremstilling av et medikament for behandling av bakterieinfeksjoner forÕrsaket i forbindelse med kolonisering av nasofarynks med patogene organismer
AU659444B2 (en) Intermediates for the manufacture of 6-fluoro-1, 4-dihydro-4-oxoquinoline carboxylic acids
GEP19991538B (en) Derivatives of Erytromycin and Pharmaceutical Composition on their Basis
AU3311095A (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
ZA919317B (en) Novel hydroxamic acid and N-hydroxyurea derivatives and their use.
WO1992019104A3 (en) Fatty acid based compositions for the control of established plant infections
ES2132678T3 (es) Sal de nimesulido hidrosoluble y su utilizacion para el tratamiento de las afecciones inflamatorias.
ATE461928T1 (de) Antibakterielle wirkstoffe
ATE274916T1 (de) Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome
ATE336997T1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
ATE246192T1 (de) Ethyliden-derivate tricyclyscher carbapenems
AU563831B2 (en) N-(2-amino-3,5-dibromobenzyl)- trans-4-amino-cyclohexanol derivatives
ES2125356T3 (es) Empleo de leflunomida para la inhibicion de interleuquina 8.
EP1123692A3 (fr) Utilisation de dérivés de polyaminoacides pour traiter la séborrhée et les désordres cutanés associés
NO982863L (no) Nye forbindelser med analgetisk effekt
DE3887686D1 (de) Bakterielle zubereitung für die prophylaxe und behandlung von entzuendungen und allergischen beschwerden.
ATE457730T1 (de) Verabreichung von produkten des 5-lipoxygenase synthesewegs zur behandlung von mikrobiellen infektionen
FR2380277A1 (fr) L'antibiotique desacetyl, dihydro 890 a9
DK1232173T3 (da) Nye fusidinsyrederivater
MX9708385A (es) Derivados novedosos de tetraciclina, composiciones que los contienen, y el uso de las mismas.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application